Alzheimer's Association International Conference Research Articles

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City.

While Latin America (LatAm) is facing an increasing burden of dementia due to the rapid aging of the population, it remains underrepresented in dementia research, diagnostics, and care. In 2023, the Alzheimer's Association hosted its eighth satellite symposium in Mexico, highlighting emerging dementia research, priorities, and challenges within LatAm. Significant initiatives in the region, including intracountry support, showcased their efforts in fostering national and international collaborations; genetic studies unveiled the unique genetic admixture in LatAm; researchers conducting emerging clinical trials discussed ongoing culturally specific interventions; and the urgent need to harmonize practices and studies, improve diagnosis and care, and use affordable biomarkers in the region was highlighted. The myriad of topics discussed at the 2023 AAIC satellite symposium highlighted the growing research efforts in LatAm, providing valuable insights into dementia biology, genetics, epidemiology, treatment, and care.

Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?

Study participants, patients, and care partners are key stakeholders in research and have asked for greater inclusion in the dissemination of scientific learning. However, the participation of general audiences in scientific conferences dedicated to Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) is not widely supported or studied. Our objectives were to evaluate the interest, level of engagement, and impact of including general audiences in a virtual dementia conference. A diverse group of lay participants, identified via community-based health advocacy groups and research centers, were invited to attend the 2021 Alzheimer's Association International Conference (AAIC), with optional small-group discussions. Participants received complimentary access to all scientific sessions and were supported via navigation tips, recommended sessions, and a glossary of frequently used terms and acronyms. Lay participants demonstrated a high level of engagement, even among those that were research-naïve, attending virtual sessions for an average of 11.7 hours across the five days and recommending a variety of sessions to each other on topics extending from prevention of dementia to new therapies and care. Most participants said they would attend the conference again and rated the quality of interaction as high, while requesting more opportunities to engage directly with researchers. General audiences, in particular research participants, are advocating for greater participation in scientific conferences. This program can serve as a model to accomplish inclusion; thereby acknowledging their invaluable contribution to science.

Alzheimer's Association International Conference (AAIC) 2022. San Diego – July 31-August 4, 2022

Alzheimer's Association International Conference (AAIC) 2022. San Diego – July 31-August 4, 2022

In Case You Haven't Heard…

Eating ultra‐processed foods such as hot dogs, sausages, burgers, French fries, soda, cakes and candies can contribute to overall cognitive decline, including areas of the brain involved in executive functioning, i.e., the ability to process information and make decisions, according to a new study. Presented Aug. 1 at the 2022 Alzheimer's Association International Conference in San Diego, the study followed over 10,000 Brazilians for up to 10 years. Those in the study who ate the most ultra‐processed foods were “more likely to be younger, women, white, had higher education and income, and were more likely to have never smoked, and less likely to be current alcohol consumers,” the researchers reported. Men and women who ate the most ultra‐processed foods had a 28% faster rate of global cognitive decline and a 25% faster rate of executive‐function cognitive decline compared with people who ate the least amount of overly processed food, CNN Health reported about the study. Researchers also have found that eating ultra‐processed foods can raise the risk of obesity, heart and circulation problems, diabetes and cancer.

Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium.

As research and services in the Mediterranean region continue to increase, so do opportunities for global collaboration. To support such collaborations, the Alzheimer's Association was due to hold its seventh Alzheimer's Association International Conference Satellite Symposium in Athens, Greece in 2021. Due to the COVID-19 pandemic, the meeting was held virtually, which enabled attendees from around the world to hear about research efforts in Greece and the surrounding Mediterranean countries. Research updates spanned understanding the biology of, treatments for, and care of people with Alzheimer's disease (AD_ and other dementias. Researchers in the Mediterranean region have outlined the local epidemiology of AD and dementia, and have identified regional populations that may expedite genetic studies. Development of biomarkers is expected to aid early and accurate diagnosis. Numerous efforts have been made to develop culturally specific interventions to both reduce risk of dementia, and to improve quality of life for people living with dementia.

Can a digital scientific conference function as a platform for facilitating two‐way learning between researchers and participants?

AbstractBackgroundResponding to requests from research participants, we piloted a program to facilitate two‐way learning between researchers and participants through the platform of a digital scientific conference.MethodParticipants were invited to attend the Alzheimer’s Association International Conference (AAIC), through a digital platform, and were offered daily small group discussions. Support was provided in the form of daily emails, navigation tips, and a glossary of frequently used terms and acronyms.ResultThe digital conference was well attended, with participants attending a broad spectrum of talks. Convening daily small group discussions was critical in creating a space where two‐way learning could occur by allowing participants to interact and share with each other as well as with research professionals. Participants provided input on research design, recruitment, outcomes, and approaches, as well as applicability of research to clinical settings.ConclusionConferences that are remotely accessible offer a unique opportunity to support the engagement and participation of individuals with limited mobility or time. Future conferences should offer research participants either free or reduced registration, and allow them to select the topics they are most interested in. We recommend providing support and a glossary of frequently used acronyms and terms. Future work is needed to replicate this approach in a more diverse group of research‐naïve participants.

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.

The Alzheimer's Association International Conference held its sixth Satellite Symposium in Sydney, Australia in 2019, highlighting the leadership of Australian researchers in advancing the understanding of and treatment developments for Alzheimer's disease (AD) and other dementias. This leadership includes the Australian Imaging, Biomarker, and Lifestyle Flagship Study of Ageing (AIBL), which has fueled the identification and development of many biomarkers and novel therapeutics. Two multimodal lifestyle intervention studies have been launched in Australia; and Australian researchers have played leadership roles in other global studies in diverse populations. Australian researchers have also played an instrumental role in efforts to understand mechanisms underlying vascular contributions to cognitive impairment and dementia; and through the Women's Healthy Aging Project have elucidated hormonal and other factors that contribute to the increased risk of AD in women. Alleviating the behavioral and psychological symptoms of dementia has also been a strong research and clinical focus in Australia.

Expanding Representation of Low and Middle Income Countries in Global Dementia Research: Commentary From the Alzheimer's Association.

Alzheimer's disease (AD) and all other dementia represent a global challenge, with an estimated 50 million individuals in the world living with dementia today. In low and middle income countries (LMICs), the burden of disease often is greater, and some of these countries are projected to have some of the largest increases in dementia prevalence during the next few decades. As the world's largest voluntary health organization dedicated to AD and all other dementia, the Alzheimer's Association is committed to its vision of a world without dementia and recognizes the needs, challenges, and opportunities for dementia research in all parts of the world, and especially in LMICs. Currently, the Association is devoting more than $215 million in funding to nearly 600 best-of-field projects in 31 countries, including a significant number of projects that advance and support LMIC-specific research. The innovative work in LMICs is focused on addressing unmet needs or challenges associated with the many unique cultural, demographic, and economic characteristics of these countries. The Association also is expanding leading global forums such as the Alzheimer's Association International Conference (AAIC). In an effort to create new learning and participation opportunities, the Association also has been partnering with other international organizations and collaborating with local leadership to provide AAIC Satellite Symposia (AAIC SS) in LMIC regions around the world. In 2021 and beyond, the Association is committed to continuing these LMIC-focused initiatives, identifying gaps in LMIC research and resources, and enhancing collaboration and communication among researchers in these regions.

Alzheimer's Association International Conference Neuroscience Next focused on early career researchers across all of neuroscience.

Alzheimer's Association International Conference Neuroscience Next focused on early career researchers across all of neuroscience.

Alzheimer's Association International Conference 2021. Denver/Virtual - July 26-30, 2021

Alzheimer's Association International Conference 2021. Denver/Virtual - July 26-30, 2021

Do infections have a role in the pathogenesis of Alzheimer disease?

The idea that infectious agents in the brain have a role in the pathogenesis of Alzheimer disease (AD) was proposed nearly 30 years ago. However, this theory failed to gain substantial traction and was largely disregarded by the AD research community for many years. Several recent discoveries have reignited interest in the infectious theory of AD, culminating in a debate on the topic at the Alzheimer's Association International Conference (AAIC) in July 2019. In this Viewpoint article, experts who participated in the AAIC debate weigh up the evidence for and against the infectious theory of AD and suggest avenues for future research and drug development.

Alzheimer's Association International Conference 2020. Virtual Conference - July 27-31, 2020

The Alzheimer's Association International Conference (AAIC) is the world's largest scientific platform to discuss Alzheimer's disease and dementia aimed at advancing science in these research areas Despite the COVID-19 pandemic preventing an in-person meeting this year, the virtual alternative set up by the association, continued with this aim, noting that this option had the potential to reach a larger global audience, with the information made available through free registration to the event The conference consisted of over 50 live sessions, 100 on-demand sessions with live QAadditionally there were networking opportunities through dedicated chatrooms in a 'networking lounge' and a virtual exhibition hall with approximately 60 exhibitors available live to discuss their products This report covers presentations on drugs in development presented throughout the conference

DOES INSULIN RESISTANCE INFLUENCE WHITE MATTER LESIONS IN NON-DIABETIC AD SUBJECTS?

This is a conference abstract from the Alzheimer's Association International Conference 2019 in Los Angeles, California from 14-18 July 2019.

P2‐358: INSULIN RESISTANCE INFLUENCES HIPPOCAMPAL GLUCOSE METABOLISM RATHER THAN HIPPOCAMPAL VOLUME IN NON‐DIABETIC ALZHEIMER'S DISEASE PATIENTS

This is a conference abstract from the Alzheimer's Association International Conference in Los Angeles, California from 14-18 July 2019.

Alzheimer's Association International Conference 2019. Los Angeles, California, USA - July 14-18, 2019

Alzheimer's Association International Conference 2019. Los Angeles, California, USA - July 14-18, 2019

Defective autophagy and Alzheimer's disease: is calcium the key?

Defective autophagy and Alzheimer's disease: is calcium the key?

WITHDRAWN

Alzheimer's & DementiaVolume 14, Issue 7S_Part_6 p. P358-P358 Sunday, July 22, 2018: Alzheimer's Association International Conference: P1-00: Poster Presentations: Poster Competition FinalistsFree Access P1-205: WITHDRAWN First published: 01 July 2018 https://doi.org/10.1016/j.jalz.2018.06.210AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume14, Issue7S_Part_6July 2018Pages P358-P358 RelatedInformation

WITHDRAWN

Alzheimer's & DementiaVolume 14, Issue 7S_Part_12 p. P665-P665 Monday, July 23, 2018: Alzheimer's Association International Conference: Poster Presentations: P2Free Access P2-001: WITHDRAWN First published: 01 July 2018 https://doi.org/10.1016/j.jalz.2018.06.685AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume14, Issue7S_Part_12July 2018Pages P665-P665 RelatedInformation

WITHDRAWN

Alzheimer's & DementiaVolume 14, Issue 7S_Part_6 p. P346-P346 Sunday, July 22, 2018: Alzheimer's Association International Conference: P1-00: Poster Presentations: Poster Competition FinalistsFree Access P1-175: WITHDRAWN First published: 01 July 2018 https://doi.org/10.1016/j.jalz.2018.06.179AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume14, Issue7S_Part_6July 2018Pages P346-P346 RelatedInformation

WITHDRAWN

Alzheimer's & DementiaVolume 14, Issue 7S_Part_9 p. P530-P530 Sunday, July 22, 2018: Alzheimer's Association International Conference: P1-00: Poster Presentations: Poster Competition FinalistsFree Access P1-519: WITHDRAWN First published: 01 July 2018 https://doi.org/10.1016/j.jalz.2018.06.530AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume14, Issue7S_Part_9July 2018Pages P530-P530 RelatedInformation